Physician profile
Colin Patrick Curran
NPI 1003810383
$26,073.41
in general payments reported to CMS, 2019-2025
99 companies · $3,577 in 2025
The $3,577 reported for 2025 was more than what 77% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,930 · 2020: $539 · 2021: $4,834 · 2022: $3,202 · 2023: $7,085 · 2024: $2,906 · 2025: $3,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,691 · Consulting Fee: $2,818 · Travel and Lodging: $793 · Education: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,690.96 |
| Consulting Fee | $2,818.00 |
| Travel and Lodging | $793.42 |
| Education | $265.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $4,469.71 | 2019-2025 | Jakafi, Niktimvo, Monjuvi |
| Astrazeneca Pharmaceuticals LP | $2,813.67 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,387.89 | 2019-2025 | Kisqali, Piqray |
| E.R. Squibb & Sons, L.L.C. | $1,359.98 | 2019-2025 | Opdivo, Eliquis, Camzyos |
| Genentech USA, INC. | $1,213.71 | 2019-2025 | Tecentriq, Venclexta, Alecensa |
| Merck Sharp & Dohme LLC | $1,049.01 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $991.95 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Pfizer INC. | $876.50 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $720.99 | 2019-2025 | Iclusig, Ninlaro, Fruzaqla |
| Daiichi Sankyo INC. | $659.53 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Amgen INC. | $645.83 | 2019-2023 | Kyprolis, Lumakras, Xgeva |
| Eisai INC. | $625.80 | 2019-2025 | |
| Astellas Pharma US INC | $609.97 | 2019-2025 | Padcev, Vyloy, Xospata |
| Glaxosmithkline, LLC. | $481.67 | 2019-2025 | Zejula, Jemperli, Ojjaara |
| Genzyme Corporation | $454.45 | 2019-2025 |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $403.33 | 2019-2025 | Cabometyx |
| Celgene Corporation | $385.63 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Lilly USA, LLC | $365.87 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $337.56 | 2019-2025 | Venclexta |
| Bayer Healthcare Pharmaceuticals INC. | $324.76 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $255.31 | 2019-2025 | Ultomiris, Soliris |
| Gilead Sciences, INC. | $237.29 | 2019-2025 | Trodelvy |
| Seagen INC. | $236.22 | 2019-2023 | Padcev, Adcetris |
| Regeneron Healthcare Solutions, INC. | $232.55 | 2021-2025 | Libtayo, Lynozyfic |
| Puma Biotechnology, INC. | $224.32 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $216.22 | 2019-2025 | Onivyde, Somatuline Depot |
| Ucb, INC. | $181.87 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $175.93 | 2021-2025 | Xpovio |
| Beigene USA, INC. | $175.58 | 2021-2025 | Brukinsa, Tevimbra |
| Servier Pharmaceuticals LLC | $160.73 | 2021-2025 | |
| Array Biopharma INC | $160.40 | 2021-2025 | Lorbrena, Braftovi, Mektovi |
| Aveo Pharmaceuticals, INC. | $155.25 | 2021-2023 | Fotivda |
| Jazz Pharmaceuticals INC. | $152.97 | 2021-2025 | |
| Sobi, INC | $148.51 | 2022-2025 | |
| Acrotech Biopharma INC. | $141.17 | 2021-2025 | Beleodaq |
| Janssen Scientific Affairs, LLC | $130.07 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $116.42 | 2019-2023 | Imbruvica, Epkinly |
| Emd Serono, INC. | $114.46 | 2022-2025 | Bavencio, Tepmetko |
| Kite Pharma, INC. | $111.16 | 2020-2025 | Yescarta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.33 | 2022-2024 | Gilotrif |
| Pharmaessentia USA Corporation | $92.39 | 2023-2025 | Besremi |
| Epizyme, INC. | $89.17 | 2021-2022 | |
| Accord Healthcare, INC. | $86.04 | 2024-2025 | |
| Genmab U.S., INC. | $82.64 | 2023-2025 | Tivdak, Epkinly |
| G1 Therapeutics, INC. | $80.97 | 2022-2023 | Cosela |
| Octapharma USA, INC. | $80.68 | 2019 | |
| Horizon Therapeutics Plc | $76.30 | 2019 | |
| Foundation Medicine, INC. | $69.13 | 2022-2023 | |
| Stemline Therapeutics INC. | $67.22 | 2023-2024 | Orserdu |
| Coherus Oncology, INC. | $64.90 | 2022-2025 | Loqtorzi |
| Novocure INC. | $64.11 | 2022-2023 | Optune |
| Sun Pharmaceutical Industries INC. | $60.88 | 2022-2024 | Yonsa, Odomzo |
| Adc Therapeutics America, INC. | $60.46 | 2022-2025 | |
| Grifols USA, LLC | $57.46 | 2019 | |
| Springworks Therapeutics, INC. | $54.11 | 2024-2025 | Ogsiveo |
| Taiho Oncology, INC. | $53.26 | 2019-2021 | |
| Beone Medicines USA, INC. | $52.40 | 2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $51.63 | 2024-2025 | Clonoseq |
| Spectrum Pharmaceuticals INC. | $50.73 | 2025 | Rolvedon |
| Deciphera Pharmaceuticals INC. | $49.45 | 2021-2023 | Qinlock |
| Mirati Therapeutics, INC. | $49.33 | 2023-2024 | Krazati |
| Dova Pharmaceuticals | $45.51 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $45.35 | 2021-2024 | Myrisk |
| Inari Medical, INC. | $44.60 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amag Pharmaceuticals, INC. | $43.43 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $41.41 | 2019-2020 | |
| Fresenius Kabi USA, LLC | $39.43 | 2023-2024 | Stimufend |
| Secura Bio, INC. | $39.15 | 2019 | |
| Organon LLC | $37.32 | 2021-2023 | Ontruzant |
| Tersera Therapeutics LLC | $37.27 | 2025 | Xermelo |
| Recordati_rare_diseases_inc. | $37.15 | 2023-2025 | Enjaymo, Sylvant |
| Cycle Pharmaceuticals INC | $35.92 | 2025 | Phyrago |
| Caris Mpi, INC. | $35.39 | 2025 | Mi Cancer Seek |
| Eusa Pharma (US) LLC | $35.35 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.78 | 2019-2020 | |
| Avyxa Pharma, LLC | $33.59 | 2024 | |
| Amneal Pharmaceuticals LLC | $33.09 | 2023-2025 | Avastin, Alymsys |
| Tg Therapeutics, INC. | $32.35 | 2022 | |
| Tempus Ai, INC | $29.90 | 2025 | Xt Cdx |
| Clovis Oncology, INC. | $29.10 | 2019-2021 | |
| Acceleron Pharma, INC. | $28.39 | 2021 | |
| Iovance Biotherapeutics, INC. | $26.53 | 2025 | Amtagvi |
| Geron Corporation | $25.89 | 2025 | Rytelo |
| Lexicon Pharmaceuticals, INC. | $24.69 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $22.24 | 2022 | |
| Menarini Silicon Biosystems, INC. | $21.92 | 2025 | |
| Legend Biotech USA INC. | $21.15 | 2025 | Carvykti |
| Mylan Institutional INC. | $20.45 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $20.01 | 2025 | Sancuso |
| Kyowa Kirin, INC. | $19.84 | 2025 | |
| Ge Healthcare | $18.10 | 2022 | |
| Roche Diagnostics Corporation | $17.79 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.61 | 2024 | Vivimusta |
| Celltrion USA INC. | $17.11 | 2025 | Vegzelma |
| Apellis Pharmaceuticals, INC. | $17.11 | 2025 | Empaveli |
| Rigel Pharmaceuticals, INC. | $14.40 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Medtronic USA, INC. | $12.80 | 2019 | |
| Nestle Healthcare Nutrition INC. | $12.48 | 2022 | |
| Verastem, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
Enhertu $407Keytruda $394Lenvima $321Opdivo $307Kisqali $284Cabometyx $252Tecentriq $180Nubeqa $178Libtayo $177Lynparza $175Tecvayli $174Jakafi $163Pluvicto $158Darzalex $157Adcetris $154Sarclisa $150Jaypirca $145Verzenio $145Venclexta $142Ibrance $140Elrexfio $137Padcev $136Imfinzi $133Lutathera $129Brukinsa $127Bosulif $127Reblozyl $127Iclusig $125Scemblix $122Lorbrena $119Gavreto $115Zejula $112Trodelvy $111Ninlaro $110Jemperli $110Imbruvica $110Pomalyst $109Alecensa $108Retevmo $107Xofigo $106Avastin $103Ultomiris $102Rozlytrek $100Fruzaqla $99.05Talvey $95.95Tukysa $94.92Braftovi $93.40Besremi $92.39Eliquis $92.26Ojjaara $88.53Welireg $88.50Calquence $87.87Vitrakvi $87.68Xpovio $86.94Camcevi $86.04Soliris $83.99Comirnaty $81.74Carvykti $80.02Beleodaq $75.92Injectafer $75.64Paxlovid $71.49Erleada $68.46Alunbrig $68.10Nerlynx $67.53Orserdu $67.22Piqray $65.30Tibsovo $63.81Yescarta $63.39Inlyta $62.16Xtandi $61.10Stivarga $60.88Niktimvo $56.16Epkinly $55.84Onivyde $55.17Cerezyme $54.86Cerdelga $54.86Ogsiveo $54.11Mektovi $53.62Vonjo $53.08Clonoseq $51.63Rolvedon $50.73Opdualag $50.52Bavencio $49.79Krazati $49.33Rybrevant $49.18Tivdak $49.01Monjuvi $48.52Blenrep $47.21Yonsa $43.59Talzenna $42.80Fabhalta $42.44Stimufend $39.43Elahere $38.61Xermelo $37.27Orgovyx $36.71Phyrago $35.92Somatuline Depot $35.76Mi Cancer Seek $35.39Zepzelca $35.01Cosela $34.59
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Curran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.